Valuation : EXACT Therapeutics

Market Cap 4.84Cr 52.12L 44.78L 42.02L 38.45L 71.38L 49Cr 72.11L 4.95Cr 1.93Cr 25Cr 1.95Cr 1.91Cr 81Cr P/E 2024
-2.49x
P/E 2025 -1x
Enterprise Value 2.45Cr 26.37L 22.66L 21.26L 19.45L 36.12L 25Cr 36.48L 2.5Cr 97.58L 13Cr 98.88L 96.73L 41Cr EV / Sales 2024
-
EV / Sales 2025 1,07,44,37,000x
Free-Float
30.97%
Yield 2024 *
-
Yield 2025 -
1 day-1.92%
1 week+10.07%
Current month-0.65%
1 month+12.50%
3 months+1.32%
6 months-55.00%
Current year-44.57%
1 week 0.7
Extreme 0.7
0.8
1 month 0.69
Extreme 0.69
0.8
Current year 0.58
Extreme 0.58
2.7
1 year 0.58
Extreme 0.58
2.78
3 years 0.58
Extreme 0.58
20
5 years 0.58
Extreme 0.58
23
10 years 0.58
Extreme 0.58
53.59
Manager TitleAgeSince
Chief Executive Officer 66 06/06/2022
Chief Operating Officer - 01/01/2012
Director of Finance/CFO - 01/10/2022
Director TitleAgeSince
Chairman 55 22/06/2018
Chairman - 08/06/2022
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap. Importance
04/01/23 Buy

Chairman

2,500 0.0083%
04/01/23 Buy

Founder

2,500 0.0083%
04/01/23 Buy

Chief Financial Officer

2,500 0.0083%
Change 5-day change 1-year change 3-year change Capi.($)
-1.92%+10.07%-69.15%-93.05% 52.05L
-2.54%-2.84%-1.77%+14.72% 4.89TCr
-0.40%+1.03%+418.57%+523.39% 4.5TCr
-1.42%+2.30%+42.67%+21.22% 4.41TCr
-1.22%-2.31%+4.82%+74.90% 4.07TCr
+0.53%-1.36%+16.87%+47.12% 3.35TCr
-0.21%+9.14% - - 1.78TCr
-0.35%-1.56%+21.42%+123.04% 1.65TCr
-1.01%+0.50%+13.91%+31.45% 1.47TCr
-1.65%-1.03%+75.93%+41.22% 1.38TCr
Average -1.02%+1.49%+58.14%+87.11% 2.75TCr
Weighted average by Cap. -1.03%+0.11%+89.42%+127.92%

Financials

2024 2025
Net sales - 0.06 0.01 0.01 0.01 0 0.01 0.6 0.01 0.06 0.02 0.31 0.02 0.02 0.98
Net income -5.23Cr -56.35L -48.42L -45.43L -41.58L -77.19L -53Cr -77.98L -5.35Cr -2.09Cr -27Cr -2.11Cr -2.07Cr -87Cr -8.7Cr -93.65L -80.47L -75.5L -69.09L -1.28Cr -88Cr -1.3Cr -8.89Cr -3.47Cr -45Cr -3.51Cr -3.44Cr -144.89Cr
Net Debt -9.89Cr -1.06Cr -91.5L -85.85L -78.57L -1.46Cr -100.48Cr -1.47Cr -10Cr -3.94Cr -51Cr -3.99Cr -3.91Cr -164.76Cr -2.39Cr -25.75L -22.13L -20.76L -19L -35.27L -24Cr -35.63L -2.45Cr -95.29L -12Cr -96.56L -94.47L -40Cr
Logo EXACT Therapeutics
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
Employees
11
Date Price Change Volume
04/26/04 NOK 0.7650 -1.92% 4,000
03/26/03 NOK 0.7800 +6.85% 33,930
02/26/02 NOK 0.7300 -2.67% 81,282
01/26/01 NOK 0.7500 -2.60% 25,156
31/26/31 NOK 0.7700 +10.79% 21,233
  1. Stock Market
  2. Stocks
  3. EXTX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!